Get the Stockscreener App
155.92
3.00%
4.54
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $155.92, with a volume of 11.72M.
It is up +3.00% in the last 24 hours and up +5.53% over the past month.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
See More
Previous Close:
$151.38
Open:
$152.8
24h Volume:
11.72M
Relative Volume:
4.06
Market Cap:
$42.96B
Revenue:
$21.37B
Net Income/Loss:
$1.41B
P/E Ratio:
39.54
EPS:
3.9437
Net Cash Flow:
$3.07B
1W Performance:
+8.29%
1M Performance:
+5.53%
6M Performance:
-20.58%
1Y Performance:
-8.27%
1-Day Range:
$151.63
$156.89
1-Week Range:
$140.11
$156.89
52-Week Range:
$140.11
$213.08
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
155.92 | 42.96B | 21.37B | 1.41B | 3.07B | 3.9437 |
ISRG
Intuitive Surgical Inc
|
404.70 | 143.33B | 10.58B | 3.00B | 2.83B | 8.2437 |
ALC
Alcon Inc
|
67.80 | 33.07B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
38.87 | 32.87B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
200.29 | 29.05B | 5.54B | 1.52B | 1.74B | 10.37 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-26 | Resumed | Goldman | Neutral |
| Feb-10-26 | Resumed | Barclays | Overweight |
| Feb-03-26 | Resumed | Citigroup | Buy |
| Sep-25-25 | Initiated | RBC Capital Mkts | Sector Perform |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| May-02-25 | Downgrade | Goldman | Buy → Neutral |
| May-02-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-02-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-01-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-01-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-22 | Resumed | Raymond James | Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-01-20 | Resumed | Goldman | Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
| May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-07-18 | Initiated | Deutsche Bank | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-18 | Resumed | BofA/Merrill | Buy |
| Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
| Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
Michael Feld sells $11,460 of Becton Dickinson stock - Investing.com
Becton Dickinson & Co (BDX) Stock Up 3.0% and Still Undervalued -- GF Score: 76/100 - GuruFocus
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
Bloodstream Infection Testing Market Size to Reach USD 1,404.68 Million by 2035 | SNS Insider - GlobeNewswire Inc.
Becton Dickinson EVP sells $160,226 in BDX shares By Investing.com - Investing.com South Africa
Becton Dickinson EVP sells $160,226 in BDX shares - Investing.com UK
AQR Trend Total Return Fund's Becton Dickinson & Co(BDX) Holding History - GuruFocus
Form 4 Becton Dickinson and Co For: 25 June By Investing.com - Investing.com Nigeria
Insider Sell: Michael Garrison Sells 1,100 Shares of Becton Dick - GuruFocus
Becton Dickinson and Co (BDX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Becton Dickinson (BDX) Issues Voluntary Recall for Select Skin Preparation Products - Insider Monkey
Becton Dickinson & Co. stock underperforms Monday when compared to competitors - MarketWatch
Becton Dickinson and Co (BDX) Institutional Confidence - TradingKey
Becton Dickinson and Co (BDX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Becton Dickinson and Co (BDX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Becton Dickinson and Co (BDX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Becton Dickinson and Co (BDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Becton Dickinson and Co (BDX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Becton Dickinson and Co (BDX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors - MarketWatch
Deals tracker: Baptist Health acquires Arkansas hospital - Modern Healthcare
BofA Trims Becton Dickinson (BDX) Target as Medtech Headwinds Persist - Insider Monkey
BofA Adjusts Price Target on Becton, Dickinson and Company to $170 From $177 - Moomoo
Becton Dickinson and Co Stock (US0758871091): Valuation Check As Shares Lag 2026 Highs - AD HOC NEWS
Is Becton, Dickinson and Company (BDX) A Good Stock To Buy Now? - Yahoo Finance
Becton Dickinson & Co Stock (US0758871091): Stock in focus after a quiet news day - AD HOC NEWS
BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $170 - Moomoo
Becton Dickinson EVP Michael Garrison sells $166,628 in stock - Investing.com UK
Tranche Update on Becton, Dickinson and Company's Equity Buyback Plan announced on January 27, 2026. - marketscreener.com
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Becton Dickinson & Co (BDX) Revenue BreakdownMain Composition - Moomoo
Becton, Dickinson and Company: - marketscreener.com
Becton, Dickinson and Company (BDX) Stock Analysis: Unpacking a 19.89% Potential Upside - DirectorsTalk Interviews
Jim Cramer on Becton, Dickinson: “I Think You Buy Some and Then You Wait” - insidermonkey.com
Becton Dickinson earnings loom as investors eye post-divestiture growth By Investing.com - Investing.com
Is It Smart To Buy Becton, Dickinson and Company (NYSE:BDX) Before It Goes Ex-Dividend? - Yahoo Finance
Becton Dickinson & Co. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
June 3, 2026Polen Thomas E Jr - Becton Dickinson
Becton Dickinson chairman, CEO Thomas E. Polen Jr. sells $404k in shares - Investing.com UK
June 2, 2026Menziuso Peter3 - Becton Dickinson
Becton Dickinson & Co. stock outperforms competitors despite losses on the day - MarketWatch
Becton Dickinson & Co stock (US0758871091): Norges Bank stake highlights interest after recent earni - AD HOC NEWS
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.48%
2.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):